5/9/2025

VCYT registers robust growth from its market-leading Decipher Prostate and Afirma tests in the first quarter of 2025.

Source: Yahoo

5/9/2025

Increased organ utilization in liver and continued OCS adoption across both liver and heart boosted TransMedics' first-quarter 2025 performance.

Source: Yahoo

5/9/2025

AMN Healthcare's dismal results in all its segments led to a soft overall first-quarter 2025 performance.

Source: Yahoo

5/9/2025

Despite strong Service and other revenues, PACB reports soft first-quarter 2025 results partly due to lower Revio system shipments.

Source: Yahoo

5/9/2025

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 2.54% (Institutional Shares) in the quarter compared to a 3.87% gain for the Russell 3000 Health Care Index (benchmark) and a 4.72% decline for the Russell […]

Source: Yahoo

5/9/2025

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against other best medical device stocks to buy now. Trump’s Tariffs Are Dividing the Medical Community On April 16, CNBC reported that Trump’s tariffs […]

Source: Yahoo

5/9/2025

Elutia Inc (ELUT) reports significant growth in its bio envelope division and strategic partnerships, while addressing production constraints and cash flow management.

Source: Yahoo

5/8/2025

Boston Scientific Corp. stock underperforms Thursday when compared to competitors

Source: MarketWatch

5/8/2025

Despite solid performances by the Labs and Immunohematology units and EMEA and Other regions, QDEL reports soft overall top-line results in first-quarter 2025.

Source: Yahoo

5/8/2025

Inogen's overall first-quarter 2025 results continue to gain from higher business-to-business sales.

Source: Yahoo

5/8/2025

DENTSPLY SIRONA's customer-centric innovation and operational efficiency drive its first-quarter 2025 performance despite global macroeconomic challenges.

Source: Yahoo

5/8/2025

The Hartford Healthcare Fund (I Share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.

Source: SeekingAlpha

5/8/2025

Zacks.com users have recently been watching Boston Scientific (BSX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Source: Yahoo

5/8/2025

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Abbott Laboratories (NYSE:ABT) and its peers.

Source: Yahoo

5/7/2025

Despite trade policy challenges, Abbott's global footprint and 90 manufacturing sites offer flexibility to manage regional risks and reroute supply chains.

Source: Yahoo

5/7/2025

Boston Scientific stock is wavering around the buy point of a double-bottom base. The company recently raised its 2025 earnings outlook.

Source: Yahoo

5/7/2025

Strength in Avanos' SNS segment drives its first-quarter 2025 performance despite global macroeconomic challenges.

Source: Yahoo

5/7/2025

Fresenius Medical's first-quarter results showcase a strong segmental performance, along with reiterating its 2025 outlook for revenue growth.

Source: Yahoo

5/7/2025

Clover Health's first-quarter 2025 results continue to benefit from the strength of its strong member retention. A decline in operating loss bodes well.

Source: Yahoo

5/7/2025

Masimo's first-quarter 2025 results continue to benefit from the strength in its Healthcare businesses despite tariff-related uncertainties.

Source: Yahoo